Yu-Hsin Lin
- Pharmaceutical Science top 0.1%
- Biomaterials top 0.5%
- Molecular Biology top 10%
- Molecular Medicine top 0.5%
- Biomedical Engineering top 5%
- Co-authors
- Hsing‐Wen SungFwu‐Long MiHsiang‐Fa LiangChiung-Tong ChenNobuhiro SuzukiChih‐Ho LaiKiran SonajeSatoko Kanematsu
- Topics
- Helicobacter pylori-related gastroenterology studies (11 papers)Advanced Drug Delivery Systems (10 papers)Nanoparticle-Based Drug Delivery (7 papers)
- Partner nations
- TaiwanUnited StatesJapan
In The Last Decade
Yu-Hsin Lin
99 papers receiving 5.1k citations
Hit Papers
Peers
Comparison fields: 5 of 154
- Pharmaceutical Science 1.4k
- Biomaterials 1.3k
- Molecular Biology 1.2k
- Molecular Medicine 818
- Biomedical Engineering 721
Countries citing papers authored by Yu-Hsin Lin
This map shows the geographic impact of Yu-Hsin Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu-Hsin Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu-Hsin Lin more than expected).
Fields of papers citing papers by Yu-Hsin Lin
This network shows the impact of papers produced by Yu-Hsin Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu-Hsin Lin. The network helps show where Yu-Hsin Lin may publish in the future.
Co-authorship network of co-authors of Yu-Hsin Lin
This figure shows the co-authorship network connecting the top 25 collaborators of Yu-Hsin Lin. A scholar is included among the top collaborators of Yu-Hsin Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu-Hsin Lin. Yu-Hsin Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 2 | |
| 5 | 19 | |
| 6 | 11 | |
| 7 | 44 | |
| 8 | 90 | |
| 9 | 23 | |
| 10 | 45 | |
| 11 | 1 | |
| 12 | 32 | |
| 13 | 39 | |
| 14 | 8 | |
| 15 | 83 | |
| 16 | 42 | |
| 17 | 161 | |
| 18 | 105 | |
| 19 | 12 | |
| 20 | 351 |
About Yu-Hsin Lin
Yu-Hsin Lin is a scholar working on Pharmaceutical Science, Endocrinology and Molecular Medicine, having authored 106 papers that have together received 5.2k indexed citations. Recurring topics across this work include Helicobacter pylori-related gastroenterology studies (11 papers), Advanced Drug Delivery Systems (10 papers) and Nanoparticle-Based Drug Delivery (7 papers). The work is most often cited by research in Pharmaceutical Science (1.4k citations), Molecular Medicine (818 citations) and Biomaterials (1.3k citations). Yu-Hsin Lin has collaborated with scholars based in Taiwan, United States and Japan. Frequent co-authors include Hsing‐Wen Sung, Fwu‐Long Mi, Hsiang‐Fa Liang, Chiung-Tong Chen, Nobuhiro Suzuki, Chih‐Ho Lai, Kiran Sonaje, Satoko Kanematsu, Mei‐Chin Chen and Sotaro Chiba. Their work appears in journals such as Biomaterials, Journal of The Electrochemical Society and Journal of Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.